0 prosjekter

H20-MSCA-Marie Sklodowska-Curie actions

Exploring the underlying mechanIsms of partial leptin reduction towards a non-invasive obesity therapy

Leptin regulates energy balance by functioning as a “satiety signal”. When identified 26 years ago, expectations were high that leptin therapies could be used for the treatment of obesity. In contrast to the successful use of leptin for treatment of individuals with lipodystrophy and complete lep...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2022-2025

Sted: Vestland

H20-MSCA-Marie Sklodowska-Curie actions

Succinate-induced leukemic stem cell formation via epigenetic remodeling of hematopoietic stem cell

In life, no matter how small, changes can have huge impact on its quality. For hematopoietic stem cells (HSC), similar can happen. Through minor shifts, from normal to pre-leukemic and finally leukemic phenotype, generation of leukemic stem cells (LSC) results in overt malignancy, such is acute m...

Tildelt: kr 2,2 mill.

Prosjektperiode: 2022-2024

Sted: Troms og Finnmark - Romsa ja Finnmárku - Tromssa ja Finmarkku

H20-MSCA-Marie Sklodowska-Curie actions

Healthcare Access in Rural Border Regions. Realizing Patient Rights Across European Borders

The fellowship – Healthcare Access in Rural Border Regions. Realizing Patient Rights Across European Borders (HARBOR) – will launch the first cross-national and multi-scalar study of cross-border interactions and their impact on access to healthcare in rural and disadvantaged border areas in Euro...

Tildelt: kr 2,3 mill.

Prosjektperiode: 2022-2024

Sted: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

The role of bacteriocins in shaping oral biofilms

In the BOB project, the role of bacteriocins in shaping oral biofilms will be investigated by moving a Spanish researcher currently working in Ireland to the Norwegian University of Life Sciences. Bacteriocins are antimicrobial peptides produced by bacteria primarily known as killer peptides, and...

Tildelt: kr 2,2 mill.

Prosjektperiode: 2022-2024

Sted: Viken

H20-FOOD-Food security, sustainable agriculture and forestry, marine and maritime and inland water research

Systemic Innovations Towards a Zero Food Waste Supply Chain

ZeroW has set the ambitious target of playing a key role in the transition of current food systems towards halving Food Loss & Waste (FLW) by 2030 and reaching near-zero FLW by 2050. ZeroW provides significant impacts through the demonstration of innovations in nine real-life food chains, by emp...

Tildelt: kr 1,3 mill.

Prosjektperiode: 2022-2025

Sted: Trøndelag - Trööndelage

H20-MSCA-Marie Sklodowska-Curie actions

SWIPT- MED: Simultaneous Wireless Information and Power Transfer for Medical Implants

The growth and extensible research in active implantable medical devices (AIMDs) have provided the opportunity for continuous and remote monitoring of patients with chronic illness. But the major technological challenge is that most of the implants operate on batteries with limited durability. It...

Tildelt: kr 3,0 mill.

Prosjektperiode: 2021-2024

Sted: Oslo

H20-ENV-Climate action, environment, resource efficiency and raw materials

ZeroPM: Zero pollution of Persistent, Mobile substances

ZeroPM will interlink and synergize prevention, prioritization and removal strategies to protect the environment and human health from persistent, mobile (PM) substances. To do this, ZeroPM will establish an evidence-based multilevel framework to guide policy, technological and market incentives ...

Tildelt: kr 29,9 mill.

Prosjektperiode: 2021-2026

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Innovations to accelerate vaccine development and manufacture

Inno4Vac proposes an ambitious programme that will harness the latest advances in immunology, disease modelling, and modelling for tackling persistent scientific bottlenecks in vaccine development and for de-risking and accelerating this process. To reach this aim the project is divided into fou...

Tildelt: kr 16,5 mill.

Prosjektperiode: 2021-2027

Sted: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

The main objective of the Project is to create BEAMER, a disease-agnostic behavioral and adherence model for improving quality, health outcomes and cost-effectiveness of healthcare, through improving the quality of life of individuals, enhance healthcare accessibility and sustainability. The mode...

Tildelt: kr 10,6 mill.

Prosjektperiode: 2021-2026

Sted: Oslo og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Artificial Intelligence Model for Cognitive Assessment for infants and Children

The development of the understanding of normal and especially pathological human brain development is as important as ever, and has the potential to unlock enormous clinical benefits. It is essential to understand the underlying reasons that leads to faulty brain development in premature babies, ...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2021-2023

Sted: Trøndelag - Trööndelage

H20-FET-Future and Emerging Technologies

OrganVision: Technology for real-time visualizing and modelling of fundamental process in living organoids towards new insights into organ-specific health, disease, and recovery

OrganVision is a revolutionary technology proposition that will break new grounds in microscopy and develop an ideal imaging solution for organoid research. It will enable life scientists to visualize life unfolding in real-time inside the cells and tissue in an organ-mimicking living tissue envi...

Tildelt: kr 14,6 mill.

Prosjektperiode: 2021-2025

Sted: Troms og Finnmark - Romsa ja Finnmárku - Tromssa ja Finmarkku

H20-HEALTH-Health, demographic change and wellbeing

Comprehensive Treatment of Chronic Patients in Rural Areas

CRANE addresses the comprehensive treatment of chronic diseases in the rural areas. Rural areas in participant regions have more than 30% of people 65+, this is 20 years advanced urban scenarios. CRANE?s model will help change citizens' self-conception from being passive patients to becoming citi...

Tildelt: kr 4,5 mill.

Prosjektperiode: 2021-2026

Sted: Agder og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Using real-world big data from eHealth, biobanks and national registries, integrated with clinical trial data to improve outcome of severe mental disorders

Mental disorders represent one of the largest burdens for the European Health Care system, due to large number of patients and a lack of efficient treatment options. Today, drug treatment of mental disorders is characterized by severe adverse effects and suboptimal response in more than a third o...

Tildelt: kr 17,9 mill.

Prosjektperiode: 2021-2025

Sted: Oslo og 2 andre

H20-FOOD-Food security, sustainable agriculture and forestry, marine and maritime and inland water research

ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

Algae4IBD's mission is to develop commercial products for Inflammatory Bowel Disease (IBD) prevention and treatment using aquatic natural biological resources. With the emerging developments in natural product, notable success has been achieved in discovering natural products and their synthetic ...

Tildelt: kr 4,6 mill.

Prosjektperiode: 2021-2025

Sted: Nordland - Nordlánnda

H20-MSCA-Marie Sklodowska-Curie actions

Artificial Intelligence in Colonoscopy for Cancer Prevention

Removal precancerous polyps (so-called adenomas) during colonoscopy reduces colorectal cancer incidence and mortality. We have recently developed artificial intelligence (AI) systems which optimise colonoscopy quality by aiming at increasing the detection of adenomas. However, it is unknown if th...

Tildelt: kr 2,3 mill.

Prosjektperiode: 2021-2023

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Ontology-driven and artificial intelligence-based repeated dose toxicity testing of chemicals for next generation risk assessment

The vision of the ONTOX consortium is to provide a functional and sustainable solution for advancing human risk assessment of chemicals without the use of animals in line with the principles of 21st century toxicity testing and next generation risk assessment. Specifically, ONTOX will deliver a g...

Tildelt: kr 12,4 mill.

Prosjektperiode: 2021-2026

Sted: Oslo

H20-FET-Future and Emerging Technologies

Immune Niches for Cancer ImmunoTherapy Enhancement

Cancer is rapidly becoming the most frequent cause of morbidity and mortality in the EU, accounting for a quarter of all deaths in EU. Without breakthroughs in treatment, cancer is likely to remain one of the biggest killers in the 21st century. Immunotherapy of cancer by checkpoint inhibitors, v...

Tildelt: kr 7,0 mill.

Prosjektperiode: 2021-2025

Sted: Trøndelag - Trööndelage

H20-INFRA-Research infrastructures

The European medical isotope programme: Production of high purity isotopes by mass separation

PRISMAP - The European medical isotope programme: Production of high purity isotopes by mass separation proposes to federate a consortium of the key European intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical research in...

Tildelt: kr 0,60 mill.

Prosjektperiode: 2021-2025

Sted: Oslo

H20-LEIT-LEIT-ICT-Information and Communication Technologies

Numerical modeling of cardiac electrophysiology at the cellular scale

Cardiovascular diseases are the most frequent cause of death worldwide and half of these deaths are due to cardiac arrhythmia, a disorder of the heart's electrical synchronization system. Numerical models of this complex system are highly sophisticated and widely used, but to match observations i...

Tildelt: kr 2,4 mill.

Prosjektperiode: 2021-2024

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN: TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY

Polycystic Ovary Syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affecting 5-10% of AYAs worldwide. It is the most frequent cause of anovulatory subfertility. There is no approved therapy for PCOS. Standard off-label treatment wit...

Tildelt: kr 3,4 mill.

Prosjektperiode: 2021-2026

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

Plastics fate and effects in the human body

The main goal of PlasticsFatE (Plastics Fate and Effects in the Human Body) is to improve our present understanding of the impact of micro- and nano-plastics (MP/NP) and associated additives/adsorbed contaminants (A/C) in the human body. Human exposure to MP/NP may result from the widespread use ...

Tildelt: kr 4,2 mill.

Prosjektperiode: 2021-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Streamlined Geriatric and Oncological evaluation based on IC Technology for holistic patient-oriented healthcare management for older multimorbid patients

Population is aging and the number of complex multimorbid patients to manage will increase sharply. Disease-centred approach is not appropriate to manage these patients. Change to a patient-centred approach will simplify care pathways, secure management and treatment decision making and decrease ...

Tildelt: kr 0,97 mill.

Prosjektperiode: 2021-2026

Sted: Oslo

H20-SOCIETY-Europe in a changing world - inclusive, innovative and reflective Societies

Key Inclusive Development Strategies for LifeLongLearning

KIDS4ALLL aims to implement a pilot action that will experiment a learning method and learning environment in formal, non-formal and informal educational contexts to address the integration challenges of migrant children. The KIDS4ALLL learning method draws on (1) knowledge acquisition (2) skills...

Tildelt: kr 2,6 mill.

Prosjektperiode: 2021-2024

Sted: Oslo

H20-FET-Future and Emerging Technologies

Towards optogenetic cortical implants for hearing impaired

Cochlear implants are the first and currently most successful sensory rehabilitation strategy, and equip thousands of hearing impaired patients. However, they suffer from strong information throughput limitations, making music perception and speech intelligibility in noise impossible, extremely d...

Tildelt: kr 5,4 mill.

Prosjektperiode: 2021-2025

Sted: Trøndelag - Trööndelage

H20-HEALTH-Health, demographic change and wellbeing

POLYRISK - Understanding human exposure and health hazard of micro- and nanoplastic contaminants in our environment

The POLYRISK project aims unraveling the risks of microplastic and nanoplastic particles (MNP) that are ubiquitous in our environment and are likely to be entering the human body via inhalation and ingestion. The most bioavailable low-micron and nano-sized MNP, pose the biggest analytical challen...

Tildelt: kr 9,2 mill.

Prosjektperiode: 2021-2025

Sted: Oslo

H20-HEALTH-Health, demographic change and wellbeing

REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi-source data

The REBECCA proposal aspires to tap into the potential of Real-world Data (RWD) for supporting groundbreaking clinical research on complex chronic conditions (CCC) as a complement to Randomised Controlled Trials (RCT). REBECCA moves beyond the analysis of Electronic health records (EHR), by combi...

Tildelt: kr 8,1 mill.

Prosjektperiode: 2021-2025

Sted: Rogaland

H20-HEALTH-Health, demographic change and wellbeing

Management of chronic cardiometabolic disease and treatment discontinuity in adult ADHD patients

TIMESPAN's main objective is to advance the management of patients with Attention Deficit Hyperactivity Disorders (ADHD) and co-occurring cardiometabolic disease by improving available treatments and risk stratification. Emerging evidence points at substantial comorbidity and shared genetics betw...

Tildelt: kr 4,3 mill.

Prosjektperiode: 2021-2026

Sted: Vestland

H20-HEALTH-Health, demographic change and wellbeing

ERA-NET: Sustained collaboration of national and regional programmes in cancer research

Cancer is a worldwide health burden and a major public health challenge. Despite significant advances in the understanding, prevention, diagnostics and treatment, cancer remains a public health problem in Europe and the world. In such a setting, translational cancer research plays a key role in s...

Tildelt: kr 6,6 mill.

Prosjektperiode: 2021-2026

Sted: Oslo og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Investigating Proxies for Understanding Trajectories: Heritage Language Maintenance and Child Second Language Acquisition in Refugee Contexts

Investigating Proxies for Understanding Trajectories: Heritage Language Maintenance and Child Second Language Acquisition in Refugee Contexts (INPUT) will examine heritage language and child second language development in the European refugee context. INPUT will significantly add to a sub-field o...

Tildelt: kr 2,1 mill.

Prosjektperiode: 2021-2023

Sted: Troms og Finnmark - Romsa ja Finnmárku - Tromssa ja Finmarkku

H20-MSCA-Marie Sklodowska-Curie actions

Nanoparticle-Based Imaging and Therapy of Chronic Pain in the Dorsal Root Ganglia (DRG)

Chronic pain is a debilitating disease, which affects approximately 1.5 billion people worldwide, and of those, approximately 4% suffer from neuropathic pain. Neuropathic pain is often described as a shooting or burning pain that can come and then disappear but equally it may become chronic, wher...

Tildelt: kr 3,1 mill.

Prosjektperiode: 2021-2025

Sted: Oslo